BACKGROUND In women, anti-Müllerian hormone (AMH) levels may represent the ovarian
follicular pool and could be a useful marker of ovarian reserve. The clinical application of …

Anti-Müllerian hormone (AMH) is a member of the transforming growth factor β family of
growth and differentiation factors. In the ovary, AMH has an inhibitory effect on primordial …

Polycystic ovary syndrome (PCOS) is the main cause of female infertility worldwide and
corresponds with a high degree of comorbidities and economic burden. How PCOS is …

BACKGROUND: The anti-Mullerian hormone (AMH) is a member of the transforming growth
factor (TGF) superfamily. In women, AMH serum levels can be almost undetectable at birth …

Purpose In this review, the current knowledge on anti-Müllerian hormone (AMH) is
presented, concerning its value in disease and IVF treatment as well as in terms of its …

In the ovary, Anti-Müllerian hormone (AMH) is produced by the granulosa cells of early
developing follicles and inhibits the transition from the primordial to the primary follicular …

Objective To assess whether antimüllerian hormone (AMH) is a predictor of implantation
and/or clinical pregnancy in women undergoing assisted reproductive technology. Design …

Reproductive aging is the decline of female fertility with age. It is caused by the decrease in
the number of growing follicles, resulting from primordial follicle pool depletion. Recently, we …

Anti‐Müllerian hormone (AMH) is a dimeric glycoprotein, a member of the transforming
growth factor (TGF) superfamily. It is produced exclusively in the gonads and is involved in …

BACKGROUND: Recently, a new marker, the anti-Müllerian hormone (AMH), has been
evaluated as a marker of ovarian response. Serum AMH levels have been measured at …